{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:04:16Z","timestamp":1790762656850,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eprac.2026.04.021","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:31:10Z","timestamp":1779319870000},"page":"1575-1582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reproductive Considerations in Females With Cystic Fibrosis"],"prefix":"10.1016","volume":"32","author":[{"given":"Marissa S.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila K.","family":"Mody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea H.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2026.04.021_bib1","series-title":"2024 Annual data report. Cystic Fibrosis Foundation Patient Registry. 2024 Annual Report","author":"Foundation","year":"2025"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.021_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.fertnstert.2019.11.025","article-title":"Electronic address aao. Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"113","year":"2020","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.021_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.rbmo.2019.04.128","article-title":"Fertility of women with cystic fibrosis: a French survey","volume":"39","author":"Tournier","year":"2019","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.021_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2018.10.009","article-title":"Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age","volume":"18","author":"Shteinberg","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.eprac.2026.04.021_bib5","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/humrep\/dem046","article-title":"International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care","volume":"22","author":"Boivin","year":"2007","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.eprac.2026.04.021_bib6","first-page":"906","article-title":"Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis","volume":"144","author":"Tizzano","year":"1994","journal-title":"Am J Pathol"},{"issue":"10290","key":"10.1016\/j.eprac.2026.04.021_bib7","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.eprac.2026.04.021_bib8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0015-0282(16)39790-4","article-title":"Water and electrolytes in cervical mucus from patients with cystic fibrosis","volume":"24","author":"Kopito","year":"1973","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.eprac.2026.04.021_bib9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jcf.2023.03.013","article-title":"Cervical mucus quality in females with and without cystic fibrosis","volume":"22","author":"Roe","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.04.021_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.773753","article-title":"The prognosis of ART is not altered in cystic fibrosis women: a case-report study","volume":"13","author":"Braham","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.eprac.2026.04.021_bib11","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1210\/en.2007-1581","article-title":"Infertility in females with cystic fibrosis is multifactorial: evidence from mouse models","volume":"149","author":"Hodges","year":"2008","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.021_bib12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcf.2014.09.008","article-title":"Cystic fibrosis (cf) and ovarian reserve: a cross-sectional study examining serum Anti-mullerian hormone (amh) in young women","volume":"14","author":"Schram","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.eprac.2026.04.021_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13048-023-01226-x","article-title":"Ovarian reserve in women with cystic fibrosis: is this a cause of sub-fertility?","volume":"16","author":"Cohen-Cymberknoh","year":"2023","journal-title":"J Ovarian Res"},{"issue":"8","key":"10.1016\/j.eprac.2026.04.021_bib14","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/humrep\/13.8.2092","article-title":"Female patients with cystic fibrosis suffer from reproductive endocrinological disorders despite good clinical status","volume":"13","author":"Johannesson","year":"1998","journal-title":"Hum Reprod"},{"issue":"Suppl 2","key":"10.1016\/j.eprac.2026.04.021_bib15","first-page":"267","article-title":"Pubertal development in cystic fibrosis: an overview","volume":"16","author":"Arrigo","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.021_bib16","doi-asserted-by":"crossref","first-page":"C563","DOI":"10.1152\/ajpcell.1999.277.3.C563","article-title":"CFTR is functionally active in GnRH-expressing GT1-7 hypothalamic neurons","volume":"277","author":"Weyler","year":"1999","journal-title":"Am J Physiol"},{"issue":"1-2","key":"10.1016\/j.eprac.2026.04.021_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mce.2005.12.032","article-title":"Critical role of CFTR in uterine bicarbonate secretion and the fertilizing capacity of sperm","volume":"250","author":"Chan","year":"2006","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"10.1016\/j.eprac.2026.04.021_bib18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/ncb1047","article-title":"Involvement of CFTR in uterine bicarbonate secretion and the fertilizing capacity of sperm","volume":"5","author":"Wang","year":"2003","journal-title":"Nat Cell Biol"},{"issue":"5","key":"10.1016\/j.eprac.2026.04.021_bib19","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/humrep\/deh773","article-title":"Increased cystic fibrosis transmembrane conductance regulator (CFTR) expression in the human hydrosalpinx","volume":"20","author":"Ajonuma","year":"2005","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.021_bib20","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/AOG.0000000000001952","article-title":"Committee opinion No. 691: carrier screening for genetic conditions","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.021_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.chest.2018.10.006","article-title":"The clinical biology of cystic fibrosis transmembrane regulator protein: its role and function in extrapulmonary disease","volume":"155","author":"Liou","year":"2019","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.021_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jcf.2021.07.019","article-title":"Pregnancy in cystic fibrosis: review of the literature and expert recommendations","volume":"21","author":"Jain","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.eprac.2026.04.021_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2019.06.003","article-title":"Pregnancy outcome in women with cystic fibrosis and poor pulmonary function","volume":"19","author":"Reynaud","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.eprac.2026.04.021_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1378\/chest.118.1.85","article-title":"Pregnancy in cystic fibrosis. Fetal and maternal outcome","volume":"118","author":"Gilljam","year":"2000","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.eprac.2026.04.021_bib25","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/1471-0528.16423","article-title":"The outcome of pregnancy in women with cystic fibrosis: a UK population-based descriptive study","volume":"127","author":"Ashcroft","year":"2020","journal-title":"BJOG"},{"issue":"10285","key":"10.1016\/j.eprac.2026.04.021_bib26","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.eprac.2026.04.021_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.chest.2024.09.019","article-title":"Impact of cystic fibrosis transmembrane conductance regulator modulators on maternal outcomes during and after pregnancy","volume":"167","author":"Jain","year":"2025","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.021_bib28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jcf.2025.03.002","article-title":"CFTR modulators and pregnancy outcomes: early findings from a nationwide cohort study","volume":"24","author":"Chouchana","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.eprac.2026.04.021_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jcf.2025.06.001","article-title":"Pregnancy and neonatal outcome following in utero exposure to CFTR modulators: a multicentre prospective case series","volume":"24","author":"Gautier","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.eprac.2026.04.021_bib30","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01208-2019","article-title":"ERS\/TSANZ task force statement on the management of reproduction and pregnancy in women with airways diseases","volume":"55","author":"Middleton","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eprac.2026.04.021_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/AOG.0000000000006084","article-title":"Pregnancy in patients with cystic fibrosis","volume":"147","author":"Pineles","year":"2026","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.021_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jcf.2025.01.007","article-title":"Contraceptive use and pregnancy in cystic fibrosis: survey findings from 10 cystic fibrosis centers","volume":"24","author":"Godfrey","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.021_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.patbio.2015.04.002","article-title":"Prenatal diagnosis of cystic fibrosis: 10-years experience","volume":"63","author":"Hadj Fredj","year":"2015","journal-title":"Pathol Biol (Paris)"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.021_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1164\/ajrccm\/143.3.457","article-title":"Screening for cystic fibrosis. Ethical and social issues","volume":"143","author":"Kerem","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"10.1016\/j.eprac.2026.04.021_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10038-004-0147-2","article-title":"Reproductive attitudes of couples having a child with cystic fibrosis in Brittany (France)","volume":"49","author":"De Braekeleer","year":"2004","journal-title":"J Hum Genet"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.021_bib36","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000004082","article-title":"Medication abortion up to 70 days of gestation: ACOG practice bulletin, number 225","volume":"136","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.eprac.2026.04.021_bib37","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1097\/AOG.0000000000002899","article-title":"ACOG Practice Bulletin No. 200: early pregnancy loss","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.eprac.2026.04.021_bib38","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/01.AOG.0000431056.79334.cc","article-title":"ACOG Practice Bulletin No. 135: second-trimester abortion","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.021_bib39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jcf.2024.01.003","article-title":"Pharmacologic contraception methods for people with cystic fibrosis: a practical review for clinicians","volume":"23","author":"Elson","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.04.021_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2016.10.012","article-title":"Contraceptive choices and preferences in a cohort of women with cystic fibrosis","volume":"121","author":"Roe","year":"2016","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.021_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"Medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.eprac.2026.04.021_bib42","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S1569-1993(25)01744-8","article-title":"125 venous thromboembolism among people with cystic fibrosis using hormonal contraceptives","volume":"24","author":"Mody","year":"2025","journal-title":"J Cystic Fibrosis"},{"issue":"1","key":"10.1016\/j.eprac.2026.04.021_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jwh.2015.5259","article-title":"Risk factors for venous thromboembolism among reproductive age women","volume":"25","author":"Westhoff","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.eprac.2026.04.021_bib44","article-title":"Safety of hormonal contraception among women with liver disease: an updated systematic review","author":"Kapp","year":"2025","journal-title":"Contraception"},{"key":"10.1016\/j.eprac.2026.04.021_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2025.03.1148","article-title":"P262 liver function among women with cystic fibrosis who use hormonal contraception","volume":"24","author":"Chin","year":"2025","journal-title":"J Cystic Fibrosis"},{"key":"10.1016\/j.eprac.2026.04.021_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2022.109925","article-title":"Effectiveness and efficacy rates of progestin-only pills: a comprehensive literature review","volume":"119","author":"Zuniga","year":"2023","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.eprac.2026.04.021_bib47","first-page":"341","article-title":"Twelve years of experience with the TCu380A and TCu220C","volume":"56","year":"1997","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.021_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa2022141","article-title":"Levonorgestrel vs. copper intrauterine devices for emergency contraception","volume":"384","author":"Turok","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2026.04.021_bib49","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/AOG.0000000000002162","article-title":"Committee Opinion No 707: Access to emergency contraception","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.021_bib50","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/GRF.0000000000000056","article-title":"Emergency contraception review: evidence-based recommendations for clinicians","volume":"57","author":"Cleland","year":"2014","journal-title":"Clin Obstet Gynecol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26009997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26009997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:44:14Z","timestamp":1790761454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26009997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1530891X26009997"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.04.021","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reproductive Considerations in Females With Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}